What’s new at ATDBio

ATDBio powers YouSeq's diagnostic innovation

ATDBio partners with NATA to advance nucleic acid therapeutics

Mark Chadwick on Nanovery and DNA Nanorobots - ATDBio Oxford Oligonucleotide Symposium 2024

Adam Cribbs on Long-Read Single-Cell Sequencing - ATDBio Oxford Oligonucleotide Symposium 2024

Professor Tom Brown on Nucleic Acid Backbones - ATDBio Oxford Oligonucleotide Symposium 2024

ATDBio Oligonucleotide Symposium 2024

YouSeq releases low-cost qPCR kit to help fight mpox virus outbreak

Announcing the ATDBio Oligonucleotide Symposium 2024

ATDBio attends 20th RSC Nucleic Acids Forum

ATDBio attends IOPC Milan

ATDBio sponsors 20th RSC Nucleic Acids Forum

New research improves accuracy of high throughput sequencing

ATDBio's Oxford site achieves ISO 9001 certification

Acquisition of ATDBio by Biotage AB to provide platform for further growth

Nature Biotechnology publishes ATDBio & University of Oxford single-cell sequencing research

ATDBio establishes molecular diagnostics lab to support customer research

New ATDBio grant to improve oligonucleotide synthesis for COVID-19 tests

ATDBio joins Innovate UK EDGE Scaleup Programme to drive global growth

Innovate UK backs ATDBio & University of Oxford research in single-cell sequencing

ATDBio featured in latest Shimadzu Customer Story